197 related articles for article (PubMed ID: 27076305)
1. Vaccinomics Approach to Tick Vaccine Development.
Contreras M; Villar M; Alberdi P; de la Fuente J
Methods Mol Biol; 2016; 1404():275-286. PubMed ID: 27076305
[TBL] [Abstract][Full Text] [Related]
2. Vaccinomics Approach to the Identification of Candidate Protective Antigens for the Control of Tick Vector Infestations and
Contreras M; Alberdi P; Fernández De Mera IG; Krull C; Nijhof A; Villar M; De La Fuente J
Front Cell Infect Microbiol; 2017; 7():360. PubMed ID: 28848718
[No Abstract] [Full Text] [Related]
3. Host Immunization with Recombinant Proteins to Screen Antigens for Tick Control.
Galay RL; Miyata T; Umemiya-Shirafuji R; Mochizuki M; Fujisaki K; Tanaka T
Methods Mol Biol; 2016; 1404():261-273. PubMed ID: 27076304
[TBL] [Abstract][Full Text] [Related]
4. Vaccinomics, the new road to tick vaccines.
de la Fuente J; Merino O
Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
[TBL] [Abstract][Full Text] [Related]
5. Strategies for new and improved vaccines against ticks and tick-borne diseases.
de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
[TBL] [Abstract][Full Text] [Related]
6. Applying proteomics to tick vaccine development: where are we?
Villar M; Marina A; de la Fuente J
Expert Rev Proteomics; 2017 Mar; 14(3):211-221. PubMed ID: 28099817
[TBL] [Abstract][Full Text] [Related]
7. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
Artigas-Jerónimo S; De La Fuente J; Villar M
Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
[TBL] [Abstract][Full Text] [Related]
8. Immunization with recombinant subolesin does not reduce tick infection with tick-borne encephalitis virus nor protect mice against disease.
Havlíková S; Ličková M; Ayllón N; Roller L; Kazimírová M; Slovák M; Moreno-Cid JA; Pérez de la Lastra JM; Klempa B; de la Fuente J
Vaccine; 2013 Mar; 31(12):1582-9. PubMed ID: 23357197
[TBL] [Abstract][Full Text] [Related]
9. Tick vaccines and the control of tick-borne pathogens.
Merino O; Alberdi P; Pérez de la Lastra JM; de la Fuente J
Front Cell Infect Microbiol; 2013; 3():30. PubMed ID: 23847771
[TBL] [Abstract][Full Text] [Related]
10. A Vaccinomics Approach for the Identification of Tick Protective Antigens for the Control of
Contreras M; Villar M; de la Fuente J
Front Physiol; 2019; 10():977. PubMed ID: 31417430
[TBL] [Abstract][Full Text] [Related]
11. Targeting the tick-pathogen interface for novel control strategies.
de la Fuente J; Kocan KM; Almazan C; Blouin EF
Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
[TBL] [Abstract][Full Text] [Related]
13. RNA interference screening in ticks for identification of protective antigens.
de la Fuente J; Almazán C; Blouin EF; Naranjo V; Kocan KM
Parasitol Res; 2005 Jun; 96(3):137-41. PubMed ID: 15824899
[TBL] [Abstract][Full Text] [Related]
14. Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
Contreras M; de la Fuente J
Vaccine; 2017 Mar; 35(9):1323-1328. PubMed ID: 28161419
[TBL] [Abstract][Full Text] [Related]
15. Targeting arthropod subolesin/akirin for the development of a universal vaccine for control of vector infestations and pathogen transmission.
de la Fuente J; Moreno-Cid JA; Canales M; Villar M; de la Lastra JM; Kocan KM; Galindo RC; Almazán C; Blouin EF
Vet Parasitol; 2011 Sep; 181(1):17-22. PubMed ID: 21561715
[TBL] [Abstract][Full Text] [Related]
16. Prevention and control strategies for ticks and pathogen transmission.
de La Fuente J; Kocan KM; Contreras M
Rev Sci Tech; 2015 Apr; 34(1):249-64. PubMed ID: 26470461
[TBL] [Abstract][Full Text] [Related]
17. Tick vaccines: current status and future directions.
de la Fuente J; Contreras M
Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
[TBL] [Abstract][Full Text] [Related]
18. The intracellular bacterium Anaplasma phagocytophilum selectively manipulates the levels of vertebrate host proteins in the tick vector Ixodes scapularis.
Villar M; López V; Ayllón N; Cabezas-Cruz A; López JA; Vázquez J; Alberdi P; de la Fuente J
Parasit Vectors; 2016 Aug; 9(1):467. PubMed ID: 27561965
[TBL] [Abstract][Full Text] [Related]
19. Tick Bioactive Molecules as Novel Therapeutics: Beyond Vaccine Targets.
Murfin KE; Fikrig E
Front Cell Infect Microbiol; 2017; 7():222. PubMed ID: 28634573
[No Abstract] [Full Text] [Related]
20. Subolesin/Akirin vaccines for the control of arthropod vectors and vectorborne pathogens.
de la Fuente J; Moreno-Cid JA; Galindo RC; Almazan C; Kocan KM; Merino O; Perez de la Lastra JM; Estrada-Peña A; Blouin EF
Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():172-8. PubMed ID: 24589118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
